Fortrea Holdings (FTRE) Invested Capital (2022 - 2026)
Fortrea Holdings (FTRE) reported Invested Capital of $536.8 million for Q1 2026, down 47.51% on a YoY basis from $1.0 billion in Q1 2025, and down 5.54% quarter-over-quarter from $568.3 million in Q4 2025.
Fortrea Holdings (FTRE) Invested Capital (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Invested Capital for 5 years, with the latest figure at $536.8 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital fell 47.51% year-over-year to $536.8 million; the trailing twelve-month figure through Mar 2026 stood at $536.8 million (down 47.51% YoY), and the FY2025 full-year result was $568.3 million, down 60.46% from the prior year.
- Invested Capital for Q1 2026 stood at $536.8 million, down from $568.3 million in the prior quarter.
- The five-year high for Invested Capital was $3.4 billion in Q1 2023, with the low at $536.8 million in Q1 2026.
- Historically, Invested Capital has averaged $1.7 billion across 5 years, with a median of $1.5 billion in 2024.
- Annual changes were most pronounced in 2024 — Invested Capital fell 11.83% — and 2025, when it slumped 60.46%.
- Fortrea Holdings' Invested Capital stood at $3.3 billion in 2022, then slumped by 47.9% to $1.7 billion in 2023, then dropped by 17.41% to $1.4 billion in 2024, then tumbled by 60.46% to $568.3 million in 2025, then decreased by 5.54% to $536.8 million in 2026.
- The last three Invested Capital figures came in at $536.8 million (Q1 2026), $568.3 million (Q4 2025), and $655.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 536.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 536.80 Mn |
| Dec 31, 2025 | 568.30 Mn |
| Sep 30, 2025 | 655.30 Mn |
| Jun 30, 2025 | 664.00 Mn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.44 Bn |
| Sep 30, 2024 | 1.51 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.65 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Sep 30, 2023 | 1.72 Bn |
| Jun 30, 2023 | 1.77 Bn |
| Mar 31, 2023 | 3.40 Bn |
| Dec 31, 2022 | 3.34 Bn |
| Jun 30, 2022 | 3.30 Bn |